Compare NVS & MCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVS | MCD |
|---|---|---|
| Founded | 1895 | 1940 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.5B | 216.0B |
| IPO Year | 1991 | N/A |
| Metric | NVS | MCD |
|---|---|---|
| Price | $141.51 | $308.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 26 |
| Target Price | $118.00 | ★ $328.13 |
| AVG Volume (30 Days) | 1.5M | ★ 3.2M |
| Earning Date | 01-30-2026 | 02-09-2026 |
| Dividend Yield | 1.83% | ★ 2.45% |
| EPS Growth | N/A | ★ 2.90 |
| EPS | 7.30 | ★ 11.72 |
| Revenue | ★ $56,372,000,000.00 | $26,264,000,000.00 |
| Revenue This Year | $9.38 | $3.92 |
| Revenue Next Year | $2.69 | $5.55 |
| P/E Ratio | ★ $19.45 | $25.95 |
| Revenue Growth | ★ 12.88 | 1.25 |
| 52 Week Low | $97.39 | $276.53 |
| 52 Week High | $143.49 | $326.32 |
| Indicator | NVS | MCD |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 50.05 |
| Support Level | $135.55 | $298.33 |
| Resistance Level | $143.49 | $314.38 |
| Average True Range (ATR) | 1.56 | 3.75 |
| MACD | 0.23 | -1.03 |
| Stochastic Oscillator | 77.06 | 43.52 |
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
McDonald's is the world's largest restaurant brand, with nearly $131 billion in systemwide sales across more than 44,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 61%), with the remainder stemming from company-operated restaurants across three segments: the United States (41% of systemwide sales), international operated markets (34%), and international developmental/licensed markets (25%).